Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2)

  1. Blanco, J.-R.
  2. Alejos, B.
  3. Moreno, S.
Aldizkaria:
PLoS ONE

ISSN: 1932-6203

Argitalpen urtea: 2020

Alea: 15

Zenbakia: 1

Mota: Artikulua

DOI: 10.1371/JOURNAL.PONE.0226724 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus